Iron acquisition in fungal pathogens of humans
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bairwa, Gaurav | - |
dc.contributor.author | Jung, Won Hee | - |
dc.contributor.author | Kronstad, James W. | - |
dc.date.available | 2019-03-08T08:58:35Z | - |
dc.date.issued | 2017-03 | - |
dc.identifier.issn | 1756-5901 | - |
dc.identifier.issn | 1756-591X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/4676 | - |
dc.description.abstract | The devastating infections that fungal pathogens cause in humans are underappreciated relative to viral, bacterial and parasitic diseases. In recent years, the contributions to virulence of reductive iron uptake, siderophore-mediated uptake and heme acquisition have been identified in the best studied and most life-threatening fungal pathogens: Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. In particular, exciting new work illustrates the importance of iron acquisition from heme and hemoglobin in the virulence of pathogenic yeasts. However, the challenge of establishing how these fungi gain access to hemoglobin in blood and to other sources of heme remains to be fully addressed. Recent studies are also expanding our knowledge of iron uptake in less-well studied fungal pathogens, including dimorphic fungi where new information reveals an integration of iron acquisition with morphogenesis and cell-surface properties for adhesion to host cells. Overall, the accumulating information provides opportunities to exploit iron acquisition for antifungal therapy, and new work highlights the development of specific inhibitors of siderophore biosynthesis and metal chelators for therapeutic use alone or in conjunction with existing antifungal drugs. It is clear that iron-related therapies will need to be customized for specific diseases because the emerging view is that fungal pathogens use different combinations of strategies for iron acquisition in the varied niches of vertebrate hosts. | - |
dc.format.extent | 13 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.title | Iron acquisition in fungal pathogens of humans | - |
dc.type | Article | - |
dc.identifier.doi | 10.1039/c6mt00301j | - |
dc.identifier.bibliographicCitation | METALLOMICS, v.9, no.3, pp 215 - 227 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000397438600002 | - |
dc.identifier.scopusid | 2-s2.0-85034786114 | - |
dc.citation.endPage | 227 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 215 | - |
dc.citation.title | METALLOMICS | - |
dc.citation.volume | 9 | - |
dc.type.docType | Review | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordPlus | FERRIC-REDUCTASE-ACTIVITY | - |
dc.subject.keywordPlus | CANDIDA-ALBICANS | - |
dc.subject.keywordPlus | ASPERGILLUS-FUMIGATUS | - |
dc.subject.keywordPlus | CRYPTOCOCCUS-NEOFORMANS | - |
dc.subject.keywordPlus | SIDEROPHORE BIOSYNTHESIS | - |
dc.subject.keywordPlus | SACCHAROMYCES-CEREVISIAE | - |
dc.subject.keywordPlus | CFEM-DOMAIN | - |
dc.subject.keywordPlus | IDENTIFY INHIBITORS | - |
dc.subject.keywordPlus | GLOBAL BURDEN | - |
dc.subject.keywordPlus | VIRULENCE | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.